Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 26,651 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CTRL Clear all

Conditions: Major Depressive Disorder
Interventions: NRX-1074 1 mg, Placebo, NRX-1074 5 mg, NRX-1074 10 mg; Drug
Lead sponsor: Naurex, Inc, an affiliate of Allergan plc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 12
States / cities: Oakland, California • Skokie, Illinois • Wichita, Kansas + 9 more

Conditions: Lupus Erythematosus, Systemic
Interventions: Acthar Gel, Placebo Gel; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 16
States / cities: Hemet, California • Upland, California • Fort Lauderdale, Florida + 12 more

Conditions: Rheumatoid Arthritis
Interventions: XOMA 052, Placebo; Drug
Lead sponsor: XOMA (US) LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 2
States / cities: Clearwater, Florida • Middleburg Heights, Ohio

Conditions: Elevated Intraocular Pressure
Interventions: AR-12286, AR-12286 vehicle; Drug
Lead sponsor: Aerie Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 8
States / cities: Pasadena, California • Petaluma, California • Brooksville, Florida + 5 more

Conditions: Familial Hypoalphalipoproteinemia
Interventions: CER-001, Placebo; Drug
Lead sponsor: Cerenis Therapeutics, SA; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Chronic Hepatitis B
Interventions: ABI-H2158, Placebo, Entecavir (ETV); Drug
Lead sponsor: Assembly Biosciences; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 13
States / cities: Los Angeles, California • Pasadena, California • Redwood City, California + 10 more

Conditions: Multiple Sclerosis
Interventions: Positive Psychology; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nonalcoholic Steatohepatitis
Interventions: B1344, Placebo; Drug · Other
Lead sponsor: Tasly Biopharmaceuticals Co., Ltd.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Glendale, California

Conditions: Infection Due to Resistant Organism
Interventions: Fecal Microbiota Transplant (FMT), Bowel preparation, Stool or perirectal swab sampling, Fasting; Biological · Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Schizophrenia
Interventions: Folic Acid, B12, Placebo; Dietary Supplement · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 68 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 3
States / cities: Boston, Massachusetts • Grand Rapids, Michigan • Rochester, New York

Conditions: Chronic Low Back Pain
Interventions: Extended release hydrocodone and acetaminophen (Vicodin CR), hydrocodone/acetaminophen extended release (Vicodin CR), placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 770 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 63
States / cities: Hueytown, Alabama • Phoenix, Arizona • Tempe, Arizona + 52 more

Conditions: Stem Cell Transplantation, Hematologic Malignancy
Interventions: Expressive Helping, Factual Writing; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • Hackensack, New Jersey

Conditions: Healthy
Interventions: PF-07328948, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Severe Hypertriglyceridemia
Interventions: Olezarsen, Placebo; Drug
Lead sponsor: Ionis Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 617 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 56
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Chula Vista, California + 51 more

Conditions: Breast Cancer, Lymphoma, Pain
Interventions: Pregabalin, Placebo; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: PSP - Progressive Supranuclear Palsy
Interventions: AADvac1, Matching Placebo; Biological
Lead sponsor: Adam Boxer; Other
Eligibility: 41 Years to 86 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: AIDS Dementia Complex, HIV Infections
Interventions: Memantine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2001
U.S. locations: 19
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 11 more

Conditions: Head and Neck Cancer
Interventions: BRIGHT, Active Control; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Depression / Major Depressive Disorder, Food Insecurity
Interventions: Medically Tailored, Home-delivered Groceries, Active Comparison Group: Monthly Grocery Gift Card; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Worcester, Massachusetts

Conditions: Methadone-maintenance Subjects
Interventions: MOA-728; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Willingboro, New Jersey

Conditions: Arthritis, Rheumatoid
Interventions: CP-690,550, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 46
States / cities: Huntsville, Alabama • Jonesboro, Arkansas • Palo Alto, California + 41 more

Conditions: Lyme Disease
Interventions: mRNA-1975, mRNA-1982, Placebo; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 807 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 20
States / cities: Milford, Connecticut • Stamford, Connecticut • Waterbury, Connecticut + 17 more

Conditions: Rotator Cuff Tendinopathy
Interventions: Dynamic Elastic Garment (DEG) brace, Corticosteroid injection; Device · Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Borderline Personality Disorder
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: New Haven, Connecticut

Search by objective public record fields.

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases

A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection

A Positive Psychology Intervention for Patients With Multiple Sclerosis

A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia

A Study of Pain Relief in Low Back Pain

Expressive Helping for Stem Cell Transplant Patients

A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants

A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1

A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0

The Medically Tailored Groceries and Mental Health Study

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

A Dynamic Elastic Garment (DEG) in Patients With Rotator Cuff Tendinopathy

Ketamine in Borderline Personality Disorder